CN Patent

CN101325944A — 用于鼻部给药的组合物

Assigned to Yissum Research Development Co of Hebrew University of Jerusalem · Expires 2008-12-17 · 17y expired

What this patent protects

磷脂、一种或多种C2－C4醇和水在制备适合于活性剂鼻内给药的囊泡组合物中的用途，其中所述的磷脂和所述的一种或多种醇在所述的组合物中的浓度分别在0.2－10重量％和12－30重量％的范围，其中所述组合物的水含量不低于30重量％。

USPTO Abstract

磷脂、一种或多种C2－C4醇和水在制备适合于活性剂鼻内给药的囊泡组合物中的用途，其中所述的磷脂和所述的一种或多种醇在所述的组合物中的浓度分别在0.2－10重量％和12－30重量％的范围，其中所述组合物的水含量不低于30重量％。

Drugs covered by this patent

Patent Metadata

Patent number
CN101325944A
Jurisdiction
CN
Classification
—
Expires
2008-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.